First Long Island Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-48,987
Closed -$3.51M 56
2016
Q4
$3.51M Buy
48,987
+150
+0.3% +$11.1K 0.61% 51
2016
Q3
$3.86M Sell
48,837
-662
-1% -$53.8K 0.7% 51
2016
Q2
$4.13M Sell
49,499
-85,705
-63% -$7.61M 0.77% 51
2016
Q1
$12.4M Sell
135,204
-23,550
-15% -$2.12M 2.37% 11
2015
Q4
$16.1M Buy
158,754
+3,845
+2% +$400K 3.05% 4
2015
Q3
$15.2M Sell
154,909
-4,595
-3% -$510K 3.15% 6
2015
Q2
$18.7M Sell
159,504
-21,740
-12% -$2.38M 3.62% 1
2015
Q1
$17.8M Sell
181,244
-4,460
-2% -$453K 3.49% 3
2014
Q4
$17.5M Buy
185,704
+9,090
+5% +$940K 3.47% 3
2014
Q3
$18.8M Buy
176,614
+7,475
+4% +$732K 4.1% 2
2014
Q2
$14M Buy
169,139
+6,880
+4% +$536K 3.29% 4
2014
Q1
$11.5M Buy
162,259
+34,639
+27% +$2.72M 2.84% 5
2013
Q4
$9.58M Buy
127,620
+36,890
+41% +$2.57M 2.42% 9
2013
Q3
$5.7M Buy
+90,730
New +$5.42M 1.6% 39

Other funds holding GILD

First Long Island Investors's GILD Position: Q1 2017 in Review

First Long Island Investors sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 48,987 shares — an estimated $3.51M sold.

First Long Island Investors first reported a position in GILD in Q3 2013 and held it in 14 quarters. The position peaked at $18.8M in Q3 2014. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • First Long Island Investors reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • First Long Island Investors sold 48,987 Gilead Sciences shares in Q1 2017, an estimated $3.51M.
  • First Long Island Investors first reported a position in Gilead Sciences in Q3 2013 and held it in 14 quarters.
  • First Long Island Investors's Gilead Sciences position peaked at $18.8M in Q3 2014.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on First Long Island Investors's 13F filing for Q1 2017, filed 11 May 2017.